BackAytu BioPharma Overview

Aytu BioPharma Total Current Liabilities

Track Aytu BioPharma's total current liabilities ($60M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$59.97M
↓ 15.18% YoYΔ $-10.73M vs prior year quarter

Peer average

Loading

Aytu BioPharma Total Current Liabilities History

Loading

Aytu BioPharma vs. peers: Total Current Liabilities Comparison

Loading

Aytu BioPharma Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aytu BioPharma (AYTU) FAQ

As of the most recent data (March 2026), AYTU shows a total current liabilities of $60M. That compares with $71M in the prior-year period — down 15.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AYTU's total current liabilities is now $60M (was $71M) — a 15.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aytu BioPharma is outperforming or lagging.

Tracking AYTU's total current liabilities over time shows whether Aytu BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $60M That compares with $71M in the prior-year period — down 15.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Aytu BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $60M) with ownership activity and broader fundamentals.

Aytu BioPharma's total current liabilities is $60M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.